STUDIES ON THE FIBRINOLYTIC SYSTEM IN HUMAN PLASMA: QUANTITATIVE DETERMINATION OF PLASMINOGEN ACTIVATORS AND PROACTIVATORSKLUFT C.1979; THROMBOSIS AND HAEMOSTASIS; DEU; DA. 1979; VOL. 41; NO 2; PP. 365-383; ABS. FRE/GER; BIBL. 2 P.Article

OCCURRENCE OF C1 INACTIVATOR AND OTHER PROTEINASE INHIBITORS IN EUGLOBULIN FRACTIONS AND THEIR INFLUENCE ON FIBRINOLYTIC ACTIVITY.KLUFT C.1976; HAEMOSTASIS; SWITZ.; DA. 1976; VOL. 5; NO 3; PP. 136-146; BIBL. 1 P. 1/2Article

Disorders of the hemostatic system and the risk of the development of thrombotic and cardiovascular diseases : limitations of laboratory diagnosisKLUFT, C.American journal of obstetrics and gynecology. 1990, Vol 163, Num 1, pp 305-312, issn 0002-9378, 8 p., . 2Article

A rebuttal : Oral contraceptives and venous thrombosis : ReplyKLUFT, C.Thrombosis and haemostasis. 2001, Vol 85, Num 5, pp 934-936, issn 0340-6245Article

DECREASED LEVELS OF HISTIDINE-RICH GLYCOPROTEIN (HRG) AND INCREASED LEVELS OF FREE PLASMINOGEN IN WOMEN ON ORAL CONTRACEPTIVES LOW IN ESTROGENJESPERSEN J; KLUFT C.1982; THROMBOSIS AND HAEMOSTASIS; ISSN 0340-6245; DEU; DA. 1982; VOL. 48; NO 3; PP. 283-285; BIBL. 14 REF.Article

PRODUCTION OF PLASMINOGEN ACTIVATOR ACTIVITY IN FACTOR XII-DEFICIENT PLASMA.KLUFT C; JENKS RL; ASTRUP T et al.1977; THROMBOSIS RES.; G.B.; DA. 1977; VOL. 10; NO 5; PP. 759-764; BIBL. 1 P. 1/2Article

Plasminogen activator inhibitorsSPRENGERS, E. D; KLUFT, C.Blood. 1987, Vol 69, Num 2, pp 381-387, issn 0006-4971Article

PLASMA KALLIKREIN-MEDIATED ACTIVATION OF THE RENIN-ANGIOTENSIN SYSTEM DOES NOT REQUIRE PRIOR ACIDIFICATION OF PRORENINDERKX FHM; SCHALEKAMP APA; BOUMA B et al.1982; J. CLIN. ENDOCRINOL. METAB.; ISSN 0021-972X; USA; DA. 1982; VOL. 54; NO 2; PP. 343-348; BIBL. 24 REF.Article

Modified crossed immunoelectrophoresis to study with whole plasma the reversible complex formation of histidine-rich glycoprotein with plasminogenKLUFT, C; LOS, P.Thrombosis and haemostasis. 1988, Vol 60, Num 3, pp 411-414, issn 0340-6245Article

Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen―Levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivatorJESPERSEN, J; KLUFT, C.Thrombosis and haemostasis. 1985, Vol 54, Num 2, pp 454-459, issn 0340-6245Article

Inhibition of tissue-type plasminogen activator in plasma of women using oral contraceptives and in normal women during a menstrual cycleJESPERSEN, J; KLUFT, C.Thrombosis and haemostasis. 1986, Vol 55, Num 3, pp 388-389, issn 0340-6245Article

A FAMILIAL HEMORRHAGIC DIATHESIS IN A DUTCH FAMILY: AN INHERITED DEFICIENCY OF ALPHA 2-ANTIPLASMINKLUFT C; VELLENGA E; BROMMER EJP et al.1982; BLOOD; ISSN 0006-4971; USA; DA. 1982; VOL. 59; NO 6; PP. 1169-1180; BIBL. 43 REF.Article

FACTOR XII-DEPENDENT FIBRINOLYSIS: A DOUBLE FUNCTION OF PLASMA KALLIKREIN AND THE OCCURRENCE OF A PREVIOUSLY UNDESCRIBED FACTOR XII- AND KALLIKREIN-DEPENDENT PLASMINOGEN PROACTIVATORKLUFT C; TRUMPI LAKSHOVEN MM; JIE AFH et al.1979; THROMBOSIS AND HAEMOSTASIS; DEU; DA. 1979; VOL. 41; NO 4; PP. 756-773; ABS. FRE/GER; BIBL. 2 P.Article

Circadian variation of fibrinolytic activity in bloodANDREOTTI, F; KLUFT, C.Chronobiology international. 1991, Vol 8, Num 5, pp 336-351, issn 0742-0528Article

Kpnl RFLP in the human histidinerich glycoprotein geneHENNIS, B. C; KLUFT, C.Nucleic acids research. 1991, Vol 19, Num 15, issn 0305-1048, p. 4311Article

Intrinsic plasma fibrinolysis: involvement of urokinase-related activity in the factor XII- independent plasminogen proactivator pathwayKLUFT, C; WIJNFGAARDS, G.The Journal of laboratory and clinical medicine. 1984, Vol 103, Num 3, pp 408-419, issn 0022-2143Article

ACUTE LYMPHOCYTIC LEUKAEMIA COMPLICATED BY HYPOFIBRINOGENAEMIA WITHOUT EVIDENCE FOR IMPAIRED FIBRINOGEN SYNTHESIS OR DISSEMINATED INTRAVASCULAR COAGULATIONVELLENGA E; VAN IMHOFF GW; STERRENBERG L et al.1983; ACTA HAEMATOLOGICA; ISSN 0001-5792; CHE; DA. 1983; VOL. 69; NO 6; PP. 419-421; BIBL. 3 REF.Article

Sensitive markers of inflammation make it possible to study the chronic process : The rise of interest in low levels of C-reactive proteinKLUFT, C; DE MAAT, M. P. M.Vascular pharmacology. 2002, Vol 39, Num 3, pp 99-104, issn 1537-1891, 6 p.Article

Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator : a randomized placebo-controlled studyMUNKVAD, S; JESPERSEN, J; GRAM, J et al.Journal of the American College of Cardiology. 1991, Vol 17, Num 4, pp 957-962, issn 0735-1097, 6 p.Article

Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectinCLEMMENSEN, I; PETERSEN, L. C; KLUFT, C et al.European journal of biochemistry (Print). 1986, Vol 156, Num 2, pp 327-333, issn 0014-2956Article

Effects on haemostasis variables by second and third generation combined oral contraceptives : A review of directly comparative studiesKLUFT, C.Current medicinal chemistry. 2000, Vol 7, Num 5, pp 585-591, issn 0929-8673Article

PCR detection of a dinucleotide repeat in the human histidine-rich glycoprotein (HRG) geneHENNIS, B. C; HAVELAAR, A. C; KLUFT, C et al.Human molecular genetics (Print). 1992, Vol 1, Num 9, issn 0964-6906, p. 781Article

Depression of factor XII-dependent fibrinolytic activity characterizes patients with early myocadial reinfarction after recombinant tissue-type plasminogen activator therapyMUNKVAD, S; JESPERSEN, J; GRAM, J et al.Journal of the American College of Cardiology. 1991, Vol 18, Num 2, pp 454-458, issn 0735-1097Article

Calcium-dependent binding of tetranectin to fibrinKLUFT, C; LOS, P; CLEMMENSEN, I et al.Thrombosis research. 1989, Vol 55, Num 2, pp 233-238, issn 0049-3848Article

Depression of tissue plasminogen activator (t-PA) activity and rise of t-PA inhibition and acute phase reactants in blood of patients with acute myocardial infarction (AMI)GRAM, J; KLUFT, C; JESPERSEN, J et al.Thrombosis and haemostasis. 1987, Vol 58, Num 3, pp 817-821, issn 0340-6245Article